Showing results (51-60 of 156) with videos related to
Sort By:
Pageof 16
Expert Opinion on Drug Delivery|September 17, 2014
Overcoming multidrug resistance with nanomedicinesAssaf Ganoth, Keren Cohen Merimi, Dan PeerExpert Opinion on Drug Delivery|June 14, 2016
Harnessing nanomedicine for therapeutic intervention in glioblastomaAnna Gutkin, Zvi R Cohen, Dan PeerCancer Letters|September 1, 2014
Modulating cancer multidrug resistance by sertraline in combination with a nanomedicineVelthe Drinberg, Rivka Bitcover, Wolf Rajchenbach, et al.Journal of Drug Targeting|October 9, 2018
Targeting central nervous system pathologies with nanomedicinesShoshy Mizrahy, Anna Gutkin, Paolo Decuzzi, et al.Cancer Research|October 20, 2004
Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor modelsDan Peer, Yaron Dekel, Dina Melikhov, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 18, 2022
Delivery strategies of RNA therapeutics to leukocytesDana Tarab-Ravski, Lior Stotsky-Oterin, Dan PeerCancer Letters|October 15, 2008
Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimenMirit Argov, Rina Kashi, Dan Peer, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|September 27, 2015
Platelet mimicry: The emperor's new clothes?Seyed Moein Moghimi, Alan Christy Hunter, Dan PeerProceedings of the National Academy of Sciences of the United States of America|March 4, 2024
Endosomal escape: A bottleneck for LNP-mediated therapeuticsSushmita Chatterjee, Edo Kon, Preeti Sharma, et al.Methods in Molecular Biology (Clifton, N.J.)|May 18, 2019
Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid NanoparticlesInbal Hazan-Halevy, Daniel Rosenblum, Srinivas Ramishetti, et al.Pageof 16